ASL in Brain Metastasis MRI Following Gamma Knife Treatment
Recruiting
N/A
Interventional Study
Brain Metastases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 60 (estimated)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Arterial spin labeling (ASL) is a non-invasive MRI technique that could help the radiologists to distinguish brain metastasis progression versus radionecrosis following gamma-knife treatment.
The primary target of the study is to establish the diagnostic performances (specificity, sensitivity) of quantitative measures of ASL in brain metastases suspected of progression/radionecrosis after GK trea…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Brain metastasis from histologically proven tumor
* GK treatment within 4 month prior to the inclusion
* Lesions suspected of progression/ radionecrosis :
i.e.≥ 25% of the size progression
* Lesion size: gadolinium enhanced part of the tumour ≥1 cm
Exclusion Criteria:
* P…
Contacts